Literature DB >> 7524155

The clinical and biological study of androgen independent prostate cancer (AI PCa).

C J Logothetis1, N M Hoosein, J T Hsieh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7524155

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.

Authors:  Jeff Holzbeierlein; Priti Lal; Eva LaTulippe; Alex Smith; Jaya Satagopan; Liying Zhang; Charles Ryan; Steve Smith; Howard Scher; Peter Scardino; Victor Reuter; William L Gerald
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

Review 2.  [Chemotherapy of hormone refractory prostate carcinoma].

Authors:  M P Wirth; J Nippgen
Journal:  Urologe A       Date:  2003-11       Impact factor: 0.639

3.  An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.

Authors:  M J Drake; W Robson; P Mehta; I Schofield; D E Neal; H Y Leung
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.